We are live on ! Find out more
PCM

Penn Capital Management Portfolio holdings

AUM $1.58B
1-Year Est. Return 81.2%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+81.2%
3 Year Est. Return
+181.03%
5 Year Est. Return
+213.86%
10 Year Est. Return
+1,021.69%
AUM
$2.78B
AUM Growth
+$369M
Cap. Flow
+$97.4M
Cap. Flow %
3.5%
Top 10 Hldgs %
14.44%
Holding
355
New
63
Increased
108
Reduced
100
Closed
55

Top Sells

Rank Stock Value
1
VPHM
VIROPHARMA INC
VPHM
+$21.4M
2
JBL icon
Jabil
JBL
+$17.2M
3
RAD
Rite Aid Corporation
RAD
+$14.3M
4
ILMN icon
Illumina
ILMN
+$12.9M
5
ACHC icon
Acadia Healthcare
ACHC
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 14.16%
2 Industrials 13.02%
3 Financials 11.08%
4 Communication Services 8.44%
5 Consumer Discretionary 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YELL
326
DELISTED
Yellow Corporation Common Stock
YELL
-560,220
Closed -$9.46M
KEY.PRG
327
DELISTED
KeyCorp Pfd
KEY.PRG
-15,707
Closed -$1.96M

Similar funds

Penn Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Penn Capital Management held 355 positions worth $2.78B, up 15% from $2.41B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penn Capital Management deployed $97.4M of net new capital in Q4 2013, opening 63 new positions and adding to 108 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,095,086 shares worth $33.2M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Rite Aid Corporation, an estimated $14.3M trimmed.

  • Penn Capital Management's largest Q4 2013 buy was NPS PHARMACEUTICALS INC: 1,095,086 shares worth $33.2M.
  • Penn Capital Management added most to Light & Wonder in Q4 2013, an estimated $19.8M increase.
  • Penn Capital Management's biggest Q4 2013 reduction was Rite Aid Corporation, cutting an estimated $14.3M.
  • Penn Capital Management fully exited VIROPHARMA INC in Q4 2013, selling an estimated $21.4M.
  • Penn Capital Management's ten largest holdings make up 14% of its $2.78B portfolio in Q4 2013.
  • Penn Capital Management opened 63 new positions and closed 55 in Q4 2013.
  • Penn Capital Management's portfolio value rose 15% quarter-over-quarter to $2.78B.

Based on Penn Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.